Get started
Author

Alessandro Valenza

Observed name: A. Valenza
OpenAlex ID: A5034241320
Apolipoprotein E ε4 Allele Differentiates the Clinical Response to Donepezil in Alzheimer’s Disease
2005 · A. Bizzarro, C. Marra, et al. · Dementia and Geriatric Cognitive Disorders · 85
Apolipoprotein E ε4 Allele Differently Affects the Patterns of Neuropsychological Presentation in Early- and Late-Onset Alzheimer’s Disease Patients
2004 · Camillo Marra, Alessandra Bizzarro, et al. · Dementia and Geriatric Cognitive Disorders · 60
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
2023 · Piero Barbanti, Gabriella Egeo, et al. · The Journal of Headache and Pain · 48
PDF
The role of brain infarcts and hippocampal atrophy in subcortical ischaemic vascular dementia
2004 · G. Gainotti, A. Acciarri, et al. · Neurological Sciences · 37
An observational study on electrolyte disorders in the acute phase of ischemic stroke and their prognostic value
2012 · Luisa Fofi, Valentina Dall’Armi, et al. · Journal of Clinical Neuroscience · 35
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study
2024 · Piero Barbanti, Gabriella Egeo, et al. · Neurology and Therapy · 19
PDF
BuChE K variant is decreased in Alzheimer’s disease not in fronto-temporal dementia
2010 · Alessandra Bizzarro, V. Guglielmi, et al. · Journal of Neural Transmission · 19
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II)
2025 · Piero Barbanti, Cinzia Aurilia, et al. · Journal of Neurology · 18
PDF
Probable Alzheimer's Disease Patients Presenting as “Focal Temporal Lobe Dysfunction” Show a Slow Rate of Cognitive Decline
2011 · Camillo Marra, Giampiero Villa, et al. · Journal of the International Neuropsychological Society · 17
Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network
2021 · Valerio Brunetti, Aldobrando Broccolini, et al. · Neurological Sciences · 15
PDF
Apoe ϵ2‐ϵ4 genotype is a possible risk factor for primary progressive aphasia
2006 · Adele Acciarri, Carlo Masullo, et al. · Annals of Neurology · 15
The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients
2010 · A. Valenza, A. Bizzarro, et al. · Neuroscience Letters · 4
A functional 5HT2A receptor polymorphism (His452Tyr) and memory performances in Alzheimer's disease
2015 · V. Guglielmi, A. Bizzarro, et al. · International Journal of Neuroscience · 3
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study
2024 · Piero Barbanti, Gabriella Egeo, et al. · Neurology and Therapy
Works count: 14
Citation count: 375
H-index: 11
I10-index: 11
Year
Topic
Type